CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway (Q39384559)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway |
scientific article |
Statements
1 reference
CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway (English)
1 reference
1 reference
Hervé Sartelet
1 reference
Tina Imbriglio
1 reference
Carine Nyalendo
1 reference
Borhane Annabi
1 reference
Michel Duval
1 reference
Raouf Fetni
1 reference
Kokta Victor
1 reference
Lubo Alexendrov
1 reference
Monique Fabre
1 reference
Gilles Vassal
1 reference
6 March 2012
1 reference
1 reference
60
1 reference
7
1 reference
1144-1155
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference